目的 观察慢性荨麻疹特异性免疫治疗(SIT)的早期疗效,同时对患者的不良反应及依从性做相应调查。方法 对206例在我院进行特异性免疫治疗的慢性荨麻疹患者资料进行汇总分析,比较治疗16周及24周两组患者的荨麻疹活动评分(UAS)及症状积分下降指数(SSRI)以判断两组的有效率,同时对脱落患者进行电话访问。结果 特异性免疫治疗24周组与治疗16周组相比RRSI下降明显(P<0.05),有效率较高(P<0.05);206例患者中有62例脱落,脱落率较高(30.1%)。结论 特异性免疫治疗对于慢性荨麻疹的症状改善明显,但脱落率高,治疗24周相比治疗16周效果更佳。

目的 研究分析牙髓血管再生术治疗年轻恒牙的临床应用疗效。方法 选取本院2012年1月—2013年12月间年轻恒牙牙髓血管再生治疗的60例患者为研究对象,按随机数方式分成两组,每组30例。对照组患者应用根尖诱导成形手术治疗,观察组患者应用牙髓血管再生术进行治疗,统计比较两组患者术后VAS评分及临床疗效。结果 观察组患者治疗总有效率为93.3%,相较于对照组患者的90.0%差异无统计学意义(P＞0.05);治疗前,两组患者VAS疼痛等级评分差异无统计学意义(P＞0.05);治疗后,患者VAS评分降低明显,且观察组显著低于对照组,差异有统计学意义(P＜0.05)。结论 临床中应用内封氢氧化钙糊剂血管再生术在年轻恒牙治疗中具有较好的应用效果,提高有效率,减轻疼痛,值得临床中应用与推广。

目的 追踪随访186例甲状腺微小乳头状癌(Papillary Thyroid Microcarcinoma,PMC)患者术后5年及10年的肿瘤复发率、生存率、及术后并发症,探讨不同手术方式对治疗甲状腺微小乳头状癌预后。方法 临床资料为1993—2003年收治的186例甲状腺微小乳头状癌患者,102例行患侧甲状腺大部分切除术(Ⅰ组),84例行患侧甲状腺全切术+峡部切除+对侧甲状腺大部分切除+中央区淋巴结清扫术(Ⅱ组)。结果 Ⅰ组患者术后5年及10年期间肿瘤复发率、生存率与Ⅱ组差别无统计学意义(P﹥0.05),对比I组,Ⅱ组患者术后发生甲状腺及甲状旁腺功能低下的发生率较高,且差别有统计学意义(P﹤0.05)。结论 甲状腺微小乳头状癌预后良好,实行患侧甲状腺大部分切除术对治疗甲状腺微小乳头状癌是安全可行的。

Objective To follow-up 186 cases of papillary thyroid microcarcinoma and analyse their tumor recurrence rate、survival rate and complicationg after 5 and 10 years postoperation, to investigate prognosis of papillary thyroid microcarcinoma from different operation approaches. Methods 186 cases of papillary thyroid microcarcinoma were from 1993 to 2003. All the patients were divided into two groups,102 cases(group Ⅰ) performed with resection of the majority of thyroid gland, and 84 caces(group Ⅱ) performed with total thyroidectomy, thyroidectomy+isthmus thyroidectomy+contralateral thyroid lobectomy+central lymph node ablation. Results The recurrence and survival rates after 5 and 10 years were not significantly different between the two groups, but compared group Ⅰ, the incidences of hypocalcemia and hypothyroidism were higher in group Ⅱ(P<0.05). Conclusion Papillary thyroid microcarcinoma had better prognosis. Resection of the majority of thyroid gland treating papillary thyroid microcarcinoma is safe and feasible.

目的 探讨双歧三联活菌联合补中益气丸治疗腹腔镜胆囊切除术后腹泻患者的临床疗效及安全性。方法 将2014年3月—2015年3月我院收治的68例腹腔镜胆囊切除术后腹泻患者随机分成观察组和对照组(每组34例),观察组患者给予双歧三联活菌联合补中益气丸治疗,对照组患者给予双歧三联活菌治疗,比较两组患者治疗前后的临床症状积分,总体临床疗效以及不良反应。结果 治疗4周后,观察组和对照组患者大便次数、大便性状积分和腹痛/腹部不适积分均明显低于治疗前(P＜0.05),同时观察组患者大便次数、大便性状积分和腹痛/腹部不适积分低于对照组患者(P＜0.05);观察组和对照组患者临床症状总积分均低于治疗前(P＜0.05),且观察组患者临床症状总积分低于对照组患者(P＜0.05);观察组患者临床疗效总有效率(91.2%)高于对照组患者临床疗效总有效率为(70.6%)(P=0.03);观察组和对照组患者治疗期间均未出现明显药物不良反应。结论 双歧三联活菌联合补中益气丸治疗腹腔镜胆囊切除术后腹泻能明显改善患者的临床症状,总体疗效较好,不良反应率较低,值得在临床上推广应用。

Objective To investigate the clinical efficacy and safety of bifid triple viable combined with buzhongyiqi pills in treatment of patients with diarrhea after Laparoscopic cholecystectomy. Methods 68 patients with diarrhea after Laparoscopic cholecystectomy in our hospital between March 2014 and March 2015 were randomly divided into observation group and control group with each 34 cases. The patients in observation group were given bifid triple viable and Buzhongyiqi pills therapy and the patients in control group were given bifid triple viable therapy. The clinical symptoms, clinical efficacy and adverse reactions were observed before and after treatment and were compared between two groups. Results After 4 weeks of treatment, the frequency of excrement, scores of excrement consistency and scores of abdominal pain and abdominal unwell in the observation group and the control group were significantly lower than those in relevant groups before treatment (P<0.05) and the frequency of excrement, scores of excrement consistency and scores of abdominal pain and abdominal unwell in observation group were significantly lower than that in the control group (P<0.05). The aggregate score of clinical symptoms in observation group and control group were both significantly lower than that in each group before treatment (P<0.05), and the aggregate score of clinical symptoms in observation group patients was significantly lower than that in the control group patients (P<0.05). The total clinical effective rate in observation group(91.2%)was significantly higher than that in control group(70.6%)(P=0.03). There were no adverse drug reactions in the observation group and the control group during treatment period. Conclusion Bifid triple viable combined with Buzhongyiqi pills in treatment of patients with diarrhea after laparoscopic cholecystectomy could significantly improve clinical symptoms and get good overall effect, which is worthy of clinical application.

目的 探讨无脊髓神经损伤伴有大骨块突入椎管的胸腰椎爆裂骨折后路间接减压与椎弓根固定技术的应用价值。方法 对42例无脊髓神经损伤伴有大骨块突入椎管的胸腰椎爆裂骨折患者行椎弓根螺钉内固定及后路间接减压术,未进行椎板切除,伤椎上下椎体与伤椎同时植钉进行撑开间接减压,术后随访观察伤椎椎体高度的恢复,节段后凸角的纠正,椎管内骨块复位情况以及有无神经损伤症状。结果 42例患者均获随访,术后平均随访30个月。间接减压患者伤椎前后缘高度分别是:术前53.8%、82.3%,术后91.7%、95.3%;节段后凸角分别是:术前27.1°,术后5.3°;椎管截面积术前平均51.2%,术后83.7％;术后各项指标与术前相比有差异(P＜0.01)。患者术后随访均无迟发性神经损伤发生。结论 对于椎管内骨块占位但无脊髓及神经损伤的胸腰椎爆裂骨折行后路间接减压椎弓根钉内固定可以达到良好的治疗效果。

Objective To investigate the effectiveness of posterior indirect decompression and internal fixation with pedicle screws in treating thoraclumbar burst fracture without spinal cord or nerve damage accompanied with Large bone protruding into the spinal canal. Methods 42 cases were treated with pedicle screw fixation and kept the lamina. Pedicle screws were inserted into injury vertebra and adjacent centrums, and braced them for indirect decompression at the same time. To observe the recovery of injured vertebral height, the correction of segmental kyphosis angle, the restoration of protruding bone fragment and presence of nerve injury symptoms. Results After the operation, the patients were followed up for average 30 months, by comparing indexes between preoperation and postoperation, indirect decompression patient's anterior and posterior flange height of vertebral body was 53.8% and 82.3% vs 91.7% and 95.3%, and the segmental kyphosis angle was 27.1° vs 5.3°, and the cross-sectional area of spinal canal was 51.2% vs 83.7% on average. There was a significant difference between the indexes of before and after the operation. In postoperation follow-up, no patient had delayed neurological damage. Conclusion Pedicle screw internal fixation with indirection decompression is an effective method to treat thoraclumbar burst fracture,with bone fragments in spinal canal and without nervous dysfunction.

目的 探讨内科治疗的高血压基底节区出血的疗效及预后相关的因素。方法 回顾性分析2005年4月—2014年12月贵阳市第二人民医院神经外科收治的174例高血压脑出血患者的临床资料,所有患者均采用内科保守治疗,对疗效及影响患者预后的因素进行分析。结果 174例患者中,死亡50例,持续植物生存状态4例,对124例存活患者进行随访,随访时间2~117个月,随访ADL分级Ⅰ级43例,Ⅱ级53例,Ⅲ级21例,Ⅳ级3例,Ⅴ级4例,预后较好者(ADL分级Ⅰ~Ⅱ级)96例,预后不良者(ADL分级Ⅲ~Ⅴ级)28例。χ²检验显示入院 GCS评分和出血量是影响患者预后的因素。结论 影响高血压基底节区脑出血患者的预后因素较多,GCS评分较高、出血量少的患者可采用内科治疗,多数患者预后较好。

Objective To investigate treatment efficacy and the factors influencing prognosis of conservative treatment of hypertensive intracerebral hemorrhage in basal ganglia. Methods A retrospective analysis was conducted on the clinical data of 174 patients with hypertensive intracerebral hemorrhage in basal ganglia who were admitted to our hospital during the period from April 2005 to December 2014. All the patients were given internal medicine conservative treatment and followed up to observe the clinical curative effect to analyze the prognosis. Results Of the 174 patients, 50 patients died and 4 patients were persistent vegetative state. 124 patients were followed up for 2-117 months and they were classified according to ability of daily life(ADL) prognosis scale: 43 cases were in I grade, 53 cases in II grade, 21 cases in III grade, 3 cases in IV grade, 4 cases in V grade. 96 cases achieved favourable outcomes and 28 cases got poor outcomes.The results of Chi square test revealed that GCS scale and intracerebral hemorrhage volume were the factors influencing prognostic of hypertensive intracerebral hemorrhage in basal ganglia. Conclusion There were many prognosis factors related with hypertensive intracerebral hemorrhage. The curative effect and prognosis in patients with conservative treatment is obvious in these patients with high GCS scale and less intracerebral hemorrhage volume.

目的 对切开复位与撬拨复位内固定术治疗SandersⅡ型跟骨骨折临床疗效进行比较。方法 回顾分析2014年10月—2016年6月陕西中医药大学附属医院收治的58例SandersⅡ型跟骨骨折患者临床资料,切开组29例,其中男24例、女5例,平均年龄(37.10±3.45)a;闭合组29例,其中男26例、女3例,平均年龄(36.60±3.15)a。采用Maryland及AOFAS评分系统评定临床功能。结果 X线显示两组患者术后Bohler角及Gissane角均恢复,比较差异没有统计学意义(P>0.05)。撬拨复位组术中出血量、住院天数及手术时间均明显少于切开复位组(P<0.05)。撬拨组出现2例针孔感染,换药后感染消失。切开组出现2例切口感染,1例切口裂开,2例刀口皮缘坏死,长期换药后全部好转;1例腓肠神经损伤。两组并发症发生率比较差异有统计学意义(P<0.05)。结论 对于治疗SandersⅡ型跟骨骨折,两组术式均能取得良好疗效,经皮撬拨复位克氏针内固定较切开复位钢板内固定具有时间成本小、创伤小、痛苦少、并发症少等优点。

目的 探讨替罗非班辅助低分子肝素治疗急性冠脉综合征合并妊娠糖尿病的临床疗效及安全性。方法 前瞻性选取本院2012年4月—2015年10月收治的80例急性冠脉综合征合并妊娠糖尿病患者,按随机数字表法分为对照组、实验组,每组40例,实验组采用替罗非班辅助低分子肝素治疗,对照组使用单独低分子肝素治疗方案,比较两组治疗后血浆蛋白-A(PAPP-A)以及超敏C反应蛋白(hs-CRP)水平;比较两组内出血情况以及血小板计数的变化。结果 两组治疗后PAPP-A以及hs-CRP水平均有所下降,实验组下降幅度高于对照组,对比差异有统计学意义(P＜0.05);两组内出血发生率分别为10.0%、40.0%,均无严重出血情况发生,实验组轻度出血3例,中度出血1例,对照组轻度出血10例,中度出血6例,实验组轻中度出血率低于对照组(P＜0.05);两组治疗前血小板计数对比差异无统计学意义(P＞0.05),治疗后实验组血小板计数下降明显,对照组血小板计数无明显变化,两组不同时间点血小板计数差异无统计学意义(P＞0.05)。结论 替罗非班辅助低分子肝素治疗急性冠脉综合征合并妊娠糖尿病患者具有一定的效果,且用药安全性较高。

目的 观察自拟中药方内服外洗结合冲击波治疗足底筋膜炎的临床疗效。方法 收集在我院门诊就诊的符合条件足底筋膜炎患者50例,采用自拟四物四藤汤内服外洗结合冲击波治疗,运用VAS评分法及疼痛减轻百分数评定治疗前与治疗后1周、2周、1月的疗效比较。结果 治疗前后VAS评分比较(P<0.05),组间比较有统计学意义,且前两周效果更明显,总有效率为94.00%,患者满意度为96.00%。结论 本治疗方法对足底筋膜炎是有明显疗效的,可以在临床上进一步推广验证。

Objective To observe clinical curative effect of TCM oral use and external wash combined with application of shock wave in the treatment of plantar fasciitis. Methods To collect 50 cases of patients with plantar fasciitis in our hospital clinic,use Siwusiteng medical herbal decoction combined with shock wave treatments, elevate VAS score and the percentage of pain relief before and after treatment at 1 week, 2 weeks, and 1 month. Results VAS score before and after treatment was statistically significant(P<0.05), and the effect of the first two weeks is more obvious. The total effective rate was 94.00%,patient satisfaction was 96.00%. Conclusion This treatment has obvious curative effect on plantar fasciitis, and it could be further promoted in clinical verification.